NURSING 6005 CHAPTER 23: DRUGS FOR MULTIPLE SCLEROSIS | LATEST ANSWERS

NURSING 6005 CHAPTER 23: DRUGS FOR MULTIPLE SCLEROSIS Test Bank MULTIPLE CHOICE 1. A patient has been newly diagnosed with multiple sclerosis (MS), and the nurse provides teaching about the medications for the disease. Which statement by the patient indicates a need for further teaching? a. “I may need to take additional drugs at times of acute relapse.” b. “I will need to take medication indefinitely.” c. “If medication is begun early, permanent remission can be achieved.” d. “Some symptoms may need to be managed with symptom-specific drugs.” 2. A 28-year-old woman is seen in the clinic after a single episode of blurred and double vision, weakness, and clumsiness lasting several days. The patient asks the nurse if she has multiple sclerosis. The nurse will tell this patient that the provider will: a. await a second clinical attack to confirm the diagnosis. b. consider her symptoms diagnostic of multiple sclerosis. c. order a magnetic resonance imaging (MRI) scan now and another when a second clinical attack occurs. d. have a definitive diagnosis based on an MRI scan ordered today. 3. A patient has been diagnosed with primary progressive multiple sclerosis for 1 year and reports a recent brief period of being symptom free. The nurse will tell the patient that this indicates what? a. Hope for long-term remission b. Temporary improvement c. Development of relapsing-remitting MS d. Development of secondary progressive MS 4. A patient is being treated with interferon beta-1a (Avonex) for relapsing-remitting MS. The patient calls the clinic to report headache, fever, chills, and muscle aches after administering a dose. What will the nurse recommend? a. Acetaminophen or ibuprofen b. Asking the provider to order a complete blood count (CBC) c. Coming to the clinic for evaluation for leukoencephalopathy d. Discontinuing the drug immediately 5. A patient with multiple sclerosis is to begin treatment with interferon beta. The patient comes to the clinic to have pretreatment laboratory tests. Which statement by the patient indicates a need for further teaching about these tests? a. “After the first year of treatment, I will need once yearly blood work.” b. “I will need to have lab tests done every 3 months for the first year.” c. “If my liver function tests are abnormal, I will need to stop using this drug.” d. “These lab tests will measure liver and bone marrow function.” 6. A patient administers interferon beta-1a SQ (Rebif) 22 mcg/0.5 mL three times each week. The patient calls the nurse to report unrelieved itching and erythema at the injection site, despite the use of topical hydrocortisone for several weeks. What will the nurse tell this patient to do? a. Apply ice to the injection site before and after the injection. b. Ask the provider to reduce the dose of interferon beta to 8.8 mcg/0.2 mL. c. Discuss using a prescription-strength hydrocortisone product with the provider. d. Take oral diphenhydramine (Benadryl).